serine has been researched along with Thrombosis in 16 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "She presented with cerebral infarction." | 1.29 | Congenital plasminogen deficiency caused by a Ser572 to Pro mutation. ( Azuma, H; Saito, S; Shigekiyo, T; Uno, Y, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, SM | 1 |
| Kim, JS | 1 |
| Kim, HJ | 1 |
| Choi, MS | 1 |
| Park, BR | 1 |
| Kim, SG | 1 |
| Ahn, H | 1 |
| Chun, HS | 1 |
| Shin, YK | 1 |
| Kim, JJ | 1 |
| Kim, DK | 1 |
| Lee, SY | 1 |
| Seo, YW | 1 |
| Kim, YH | 1 |
| Kim, CS | 1 |
| Alagha, A | 1 |
| Moman, E | 1 |
| Adamo, MF | 1 |
| Nolan, KB | 1 |
| Chubb, AJ | 1 |
| Teofili, L | 1 |
| Giona, F | 1 |
| Torti, L | 1 |
| Cenci, T | 1 |
| Ricerca, BM | 1 |
| Rumi, C | 1 |
| Nunes, V | 1 |
| Foà, R | 1 |
| Leone, G | 1 |
| Martini, M | 1 |
| Larocca, LM | 1 |
| Di Santo, A | 1 |
| Amore, C | 1 |
| Dell'Elba, G | 1 |
| Manarini, S | 1 |
| Evangelista, V | 1 |
| Wu, Y | 1 |
| Ahmad, SS | 1 |
| Zhou, J | 1 |
| Wang, L | 1 |
| Cully, MP | 1 |
| Essex, DW | 1 |
| Best, D | 1 |
| Senis, YA | 1 |
| Jarvis, GE | 1 |
| Eagleton, HJ | 1 |
| Roberts, DJ | 1 |
| Saito, T | 1 |
| Jung, SM | 1 |
| Moroi, M | 1 |
| Harrison, P | 1 |
| Green, FR | 1 |
| Watson, SP | 1 |
| MUSTARD, JF | 1 |
| MEDWAY, W | 1 |
| DOWNIE, HG | 1 |
| ROWSELL, HC | 1 |
| TURNER, DL | 1 |
| SILVER, MJ | 1 |
| BACZYNSKI, E | 1 |
| GIORDANO, N | 1 |
| RODALEWICZ, I | 1 |
| Jin, L | 1 |
| Pandey, P | 1 |
| Babine, RE | 1 |
| Gorga, JC | 1 |
| Seidl, KJ | 1 |
| Gelfand, E | 1 |
| Weaver, DT | 1 |
| Abdel-Meguid, SS | 1 |
| Strickler, JE | 1 |
| Picard, V | 1 |
| Présot, I | 1 |
| Scarabin, PY | 1 |
| Aiach, M | 1 |
| Emmerich, J | 1 |
| Alhenc-Gelas, M | 1 |
| Azuma, H | 1 |
| Uno, Y | 1 |
| Shigekiyo, T | 1 |
| Saito, S | 1 |
| Gruel, Y | 1 |
| Pacouret, G | 1 |
| Bellucci, S | 1 |
| Caen, J | 1 |
| Van Aken, H | 1 |
| Bode, C | 1 |
| Darius, H | 1 |
| Diehm, C | 1 |
| Encke, A | 1 |
| Gulba, DC | 1 |
| Haas, S | 1 |
| Hacke, W | 1 |
| Puhl, W | 1 |
| Quante, M | 1 |
| Riess, H | 1 |
| Scharf, R | 1 |
| Schellong, S | 1 |
| Schrör, T | 1 |
| Schulte, KL | 1 |
| Tebbe, U | 1 |
| Das, J | 1 |
| Kimball, SD | 1 |
| Reid, JA | 1 |
| Wang, TC | 1 |
| Lau, WF | 1 |
| Roberts, DG | 1 |
| Seiler, SM | 1 |
| Schumacher, WA | 1 |
| Ogletree, ML | 1 |
| Fry, ET | 1 |
| Mack, DL | 1 |
| Monge, JC | 1 |
| Billadello, JJ | 1 |
| Sobel, BE | 1 |
| Perlick, E | 1 |
1 review available for serine and Thrombosis
| Article | Year |
|---|---|
Anticoagulation: the present and future.
Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzyla | 2001 |
15 other studies available for serine and Thrombosis
| Article | Year |
|---|---|
Purification and characterization of a novel fibrinolytic α chymotrypsin like serine metalloprotease from the edible mushroom, Lyophyllum shimeji.
Topics: Agaricales; Amino Acid Sequence; Chromatography, Gel; Chymotrypsin; Electrophoresis, Polyacrylamide | 2014 |
Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity.
Topics: Arginine; Aspirin; Carboxylic Acids; Catalytic Domain; Chemistry, Pharmaceutical; Drug Design; Ester | 2009 |
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Asparagine; Child; Child, Presc | 2010 |
Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets.
Topics: Blood Platelets; Coagulants; Gene Expression Regulation; Glycogen Synthase Kinase 3; Humans; Macroph | 2011 |
The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis.
Topics: Animals; Cysteine; Hemostasis; Humans; Male; Mice; Mice, Inbred C57BL; Mutagenesis, Site-Directed; M | 2012 |
GPVI levels in platelets: relationship to platelet function at high shear.
Topics: Alleles; Animals; Blood Platelets; Cell Adhesion; Collagen; Crotalid Venoms; Flow Cytometry; Genetic | 2003 |
Effects of intravenous phospholipid containing phosphatidyl serine on blood clotting with particular reference to the Russell's viper venom time.
Topics: Blood Coagulation; Humans; Phosphatidylethanolamines; Phosphatidylserines; Phospholipids; Prothrombi | 1962 |
SYNTHESIS AND ACTIVITY IN BLOOD CLOTTING SYSTEMS OF UNSATURATED RACEMIC PHOSPHATIDYL SERINES.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Chemical Phenomena; Chemistry; Glyceride | 1964 |
Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions.
Topics: Anticoagulants; Binding Sites; Catalytic Domain; Chromatography, High Pressure Liquid; Crystallograp | 2005 |
Antithrombin Cambridge II (A384S): prevalence in patients of the Paris Thrombosis Study (PATHROS).
Topics: Alanine; Antithrombin III; Case-Control Studies; Humans; Mutation; Paris; Serine; Thrombosis | 2007 |
Congenital plasminogen deficiency caused by a Ser572 to Pro mutation.
Topics: Adult; Base Sequence; Blotting, Southern; Cerebral Infarction; DNA Restriction Enzymes; Female; Huma | 1993 |
Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin.
Topics: Aged; Anticoagulants; Femoral Vein; Genetic Variation; Heparin, Low-Molecular-Weight; Humans; Male; | 1997 |
Thrombin active site inhibitors: chemical synthesis, in vitro and in vivo pharmacological profile of a novel and selective agent BMS-189090 and analogues.
Topics: Animals; Binding Sites; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug | 2002 |
Labeling of human clots in vitro with an active-site mutant of t-PA.
Topics: Humans; In Vitro Techniques; Iodine Radioisotopes; Isotope Labeling; Mutation; Radionuclide Imaging; | 1990 |
[Thrombophilia in early and late sclerosis].
Topics: Age Factors; Anticoagulants; Arteries; Arteriosclerosis; Dipyridamole; Humans; Lipid Metabolism; Nuc | 1968 |